MModal Inc. (NASDAQ/GS: MODL), a leading provider of clinical
documentation services and Speech Understanding™ technologies,
today announced the following preliminary results for the three and
six-month periods ended June 30, 2012. First half 2012 net revenues
are consistent with the Company’s previous guidance of $230 million
to $240 million.
Net revenues for the second quarter of 2012 are expected to be
$116.0 million compared with $108.4 million for the prior-year
period. Net revenues for the first half of 2012 are expected to be
$233.4 million compared with $219.7 million in the prior-year
period.
Adjusted EBITDA for the second quarter of 2012 is expected to be
$24.9 million compared with $27.6 million in the prior-year period.
Adjusted EBITDA for the first half of 2012 is expected to be $51.4
million compared with $54.3 million for the prior-year period.
Net income attributable to MModal Inc. for the second quarter of
2012 is expected to be $3.0 million, or $0.05 per fully diluted
share, compared with $5.1 million, or $0.11 per fully diluted
share, for the prior-year period. Net income attributable to MModal
Inc. for the first half of 2012 is expected to be $177 thousand, or
$0.00 per fully diluted share, compared with $14.4 million, or
$0.17 per fully diluted share, for the prior-year period.
Adjusted Net Income for the second quarter of 2012 is expected
to be $11.8 million, or $0.21 per fully diluted share, compared
with $16.3 million, or $0.31 per fully diluted share, in the
prior-year period. Adjusted Net Income for the first half of 2012
is expected to be $28.5 million, or $0.50 per fully diluted share,
compared with $32.4 million, or $0.63 per fully diluted share, in
the prior-year period.
The Company will announce final results for the second quarter
and first half of 2012 after the market closes on August 7, 2012,
and will host a conference call on August 8, 2012, at 9:00 a.m. ET
to offer prepared comments on the results.
About M*Modal
M*Modal is a leading provider of clinical transcription
services, clinical documentation workflow solutions, advanced
cloud-based Speech Understanding™ technology, and advanced
unstructured data analytics. Recognized as the largest clinical
transcription service in the U.S. with a global network of medical
editors, M*Modal also offers voice to text solutions to capture the
complete patient story, codifies the doctor’s narrative to
automatically populate EHRs and other key healthcare information
systems, delivers computer-assisted coding to support ICD-9 and the
transition to ICD-10, and provides highly advanced analytical tools
for exploring the richness within the “unstructured” narrative for
improvements in quality of care, greater physician satisfaction and
lower operational costs.
Forward-Looking Statements
Information provided and statements contained in this press
release that are not purely historical, such as statements
regarding our expected results for the first half of 2012 and the
second quarter of 2012, are forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, Section 21E
of the Securities Exchange Act of 1934 and the Private Securities
Litigation Reform Act of 1995. Such forward-looking statements only
speak as of the date of this press release and the Company assumes
no obligation to update the information included in this press
release. Statements made in this press release that are
forward-looking in nature may involve risks and uncertainties.
Accordingly, readers are cautioned that any such forward-looking
statements are not guarantees of future performance and are subject
to certain risks, uncertainties and assumptions that are difficult
to predict, including, without limitation, specific factors
discussed herein and in other releases and public filings made by
the Company (including filings by the Company with the Securities
and Exchange Commission). Although the Company believes that the
expectations reflected in such forward-looking statements are
reasonable as of the date made, expectations may prove to have been
materially different from the results expressed or implied by such
forward-looking statements. Unless otherwise required by law, the
Company also disclaims any obligation to update its view of any
such risks or uncertainties or to announce publicly the result of
any revisions to the forward-looking statements made in this press
release.
The preliminary results reported in this press release are not
final. The Company’s actual results could differ materially from
these estimates based on its completion of the review process and
other developments that may arise between now and the time the
financial results for the second quarter of 2012 are finalized.
This preliminary financial data has been prepared by and is the
responsibility of management. These results have not been audited
or reviewed, nor have any other review procedures been performed
with respect to this preliminary data by the Company’s independent
auditors.
Non-GAAP Financial Measures
In addition to the United States generally accepted
accounting principles, or GAAP, results provided throughout this
document, M*Modal has provided certain non-GAAP financial
measures to help evaluate the results of our performance. The
Company believes that these non-GAAP financial measures, when
presented in conjunction with comparable GAAP financial measures,
are useful to both management and investors in analyzing the
Company’s ongoing business and operating performance. The Company
believes that providing the non-GAAP information to investors, in
addition to the GAAP presentation, allows investors to view the
Company’s financial results in the way that management views
financial results. The tables attached to this press release
include a reconciliation of these historical non-GAAP financial
measures to the most directly comparable GAAP financial
measures.
Adjusted EBITDA
Adjusted EBITDA is a metric used by management to measure
operating performance. Adjusted EBITDA is defined as net income
attributable to MModal Inc., as applicable, plus net income
attributable to noncontrolling interests, income taxes, interest
expense, net, depreciation and amortization, (benefit) cost of
legal proceedings, settlements, and accommodations, acquisition and
restructuring charges, other income, gain on sale of investment,
realized (loss) gain on settlement of foreign currency hedges,
amortization of core technologies and share-based compensation and
other non-cash awards. The realized (loss) gain on settlement of
foreign currency hedges is a component of other income, as reported
in the Consolidated Statements of Operations. The amortization of
core technologies is a component of cost of revenues, as reported
in the Consolidated Statements of Operations. Share-based
compensation and other non-cash awards represents only the portion
of such expense that is a component of selling, general and
administrative expense, as reported in the Consolidated Statements
of Operations, as it excludes such expense attributable to the
Company's restructuring actions.
We present Adjusted EBITDA as a supplemental performance measure
because we believe it facilitates operating performance comparisons
from period to period by excluding the following:
- potential differences caused by
variations in capital structures (affecting interest expense, net),
tax positions (such as the impact on periods or companies for
changes in effective tax rates), the age and book depreciation of
fixed assets (affecting depreciation expense);
- the impact of non-cash charges;
and
- the impact of acquisition and
integration related charges and restructuring charges.
Because Adjusted EBITDA facilitates internal comparisons of
operating performance on a more consistent basis, we also use
Adjusted EBITDA in measuring our performance relative to that of
our competitors. Adjusted EBITDA is not a measurement of our
financial performance under GAAP and should not be considered as an
alternative to net income, operating income or any other
performance measures derived in accordance with GAAP or as an
alternative to cash flow from operating activities as measures of
our profitability or liquidity. We understand that although
Adjusted EBITDA is frequently used by securities analysts, lenders
and others in their evaluation of companies, Adjusted EBITDA has
limitations as an analytical tool, and you should not consider it
in isolation, or as a substitute for analysis of our results as
reported under GAAP. Some of these limitations are:
- Adjusted EBITDA does not reflect our
cash expenditures or future requirements for capital expenditures
or contractual commitments;
- Adjusted EBITDA does not reflect
changes in, or cash requirements for, our working capital
needs;
- Although depreciation is a non-cash
charge, the assets being depreciated will often have to be replaced
in the future, and Adjusted EBITDA does not reflect any cash
requirements for such replacements; and
- Other companies in our industry may
calculate Adjusted EBITDA differently than we do, limiting its
usefulness as a comparative measure.
Adjusted Net Income
Adjusted Net Income, a non-GAAP financial measure, is defined by
the Company as Adjusted EBITDA less amortization expense for
capitalized intangible assets (excluding acquired intangibles),
less interest expense (net of non-cash interest), and less current
tax provision. We measure Adjusted Net Income based on Proforma
Shares Outstanding (see below). Management believes that
utilization of Adjusted Net Income is an important non-GAAP
financial measure of our normalized operating results.
Proforma Shares Outstanding
For purposes of evaluating our results on per-share metrics,
many of our computations utilize proforma share computations. Our
measure of proforma shares includes our Basic and Diluted share
computations utilized for GAAP purposes, plus our estimate of the
impacts of common stock equivalents which consists of stock
options, restrictive stock issuable to certain key employees,
shares issued to former principal stockholders, shares issued to
former principal stockholders and shares issued in our initial
public offering, our private exchange offer, our public exchange
offer and our short-form merger with MModal MQ Inc. (f/k/a MedQuist
Inc.). The pro forma shares are calculated as if the shares that
were issued to former principal stockholders and in our initial
public offering, our private exchange offer, our public exchange
offer and our short-form merger were issued and outstanding as of
January 1, 2011.
MModal Inc. and
Subsidiaries (In thousands, except per share amounts)
Preliminary Results Unaudited
Three Months Ended June 30, Six Months Ended June
30, 2012 2011 2012
2011 Net revenues $ 115,957 $ 108,439
$ 233,357 $ 219,675
Net income
attributable to MModal Inc. $ 3,046 $ 5,135 $ 177
$ 14,447
Net income per common share
Basic $ 0.06 $ 0.11 $ - $ 0.17 Diluted $ 0.05 $ 0.11 $ - $ 0.17
Adjusted EBITDA: Net income attributable to MModal
Inc. $ 3,046 $ 5,135 $ 177 $ 14,447 Net income attributable to
noncontrolling interests - 271 - 1,777 Income tax provision
(benefit) 836 886 (413 ) 2,030 Interest expense, net 7,712 6,961
15,510 13,998 Depreciation and amortization 12,155 8,879 24,544
17,297 (Benefit) cost of legal proceedings, settlements and
accommodations (211 ) 581 329 (6,932 ) Acquisition and
restructuring (1) 5,287 4,391 16,373 11,269 Other income (814 )
(530 ) (2,678 ) (1,473 ) Gain on sale of investment (4,439 ) -
(4,439 ) - Realized (loss) gain on settlement of foreign currencies
(1,383 ) 377 (2,260 ) 534 Amortization of core technologies 490 -
490 - Share-based compensation and other non-cash awards
2,182 611 3,778
1,321
Adjusted EBITDA $ 24,861 $
27,562 $ 51,411 $ 54,268 (1)
Includes $1.5 million in share-based compensation expense for the
three and six months ended June 30, 2012.
Adjusted net income: Adjusted EBITDA $ 24,861 $
27,562 $ 51,411 $ 54,268 Less: Depreciation and amortization
(excluding acquired intangibles) 4,674 4,362 9,366 8,265 Cash
interest (total expenses less non-cash) 6,175 6,130 12,583 12,309
Current tax provision 2,210 727
1,006 1,325
Adjusted
net income $ 11,802 $ 16,343 $
28,456 $ 32,369
Adjusted net income per
share: Basic $ 0.21 $ 0.32 $ 0.52 $ 0.64 Diluted $ 0.21 $ 0.31
$ 0.50 $ 0.63
VictoryShares West End U... (NASDAQ:MODL)
Gráfica de Acción Histórica
De Ene 2025 a Feb 2025
VictoryShares West End U... (NASDAQ:MODL)
Gráfica de Acción Histórica
De Feb 2024 a Feb 2025